Medical News

RSS

Scientists identify potential drug therapy target for malaria

Scientists at Washington University School of Medicine in St. Louis have identified a protein made by the malaria parasite that is essential to its ability to take over human red blood cells.

4 Feb 2010

Discovery Health, NORD partner for Rare Disease Day

The National Organization for Rare Disorders (NORD) announced that Discovery Health and its new program, DISEASE DETECTIVES, will serve as media and program partners for Rare Disease Day on February 28, 2010.

4 Feb 2010

Sermo announces a new report on evolving trends in CML

Sermo, the world's largest online community for physicians, today announced a Sermo Event™ Report titled "Evolving Trends in CML." The new report measures the impact of ENESTnd trial data on Oncologists' use of Tasigna (Novartis), Sprycel (Bristol Myers-Squibb) and Gleevec (Novartis) in newly diagnosed CML patients and assesses overall trends in CML monitoring and management. While Gleevec will likely remain the #1 treatment, there will be a close race for the runner-up spot amongst second-generation tyrosine kinase inhibitors in the front line setting.

4 Feb 2010

Immigrants may be healthier than long-term residents

New immigrants to North America may be less likely to have a stroke at a young age than long-time residents, according to a study published in the February 3, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

4 Feb 2010

Helicos BioSciences to install Single Molecule and Genetic Analysis Systems at SLI and Stanford University

Helicos BioSciences Corporation today announced the completion of the sale of a Helicos® Single Molecule System to the St. Laurent Institute (SLI). The installation of the system is expected to be completed in early February.

4 Feb 2010

Penrose-St. Francis Health Systems selects CardiacAssist's TandemHeart System

CardiacAssist Inc. announced today that Penrose-St. Francis Health Systems, Colorado Springs, Colo., has adopted the company’s TandemHeart® System.

4 Feb 2010

New discovery lays foundation for development of new anti-HIV drugs

A team of scientists at The Scripps Research Institute has identified two compounds that act on novel binding sites for an enzyme used by the human immunodeficiency virus (HIV), the virus that causes AIDS.

4 Feb 2010

NAE and IOM join for panel discussion on 'Engineering Innovations in Healthcare'

WHAT:The National Academy of Engineering (NAE) and the Institute of Medicine (IOM) will join together for the first time at the regional meeting and panel discussion on "Engineering Innovations in Healthcare" at the University of Miami.

4 Feb 2010

Low Vision of Michigan introduces new device for RP patients

To commemorate Low Vision Awareness Month this February, Dr. Sheldon Smith, optometrist at Low Vision of Michigan, P.C., is offering free evaluations to patients diagnosed with retinitis pigmentosa (RP), a leading cause of low vision, in hopes that they might be candidates for a brand-new device designed to enhance or restore sight.

4 Feb 2010

UCSF studies show relationship between Alzheimer's disease and smoking

A UCSF analysis of published studies on the relationship between Alzheimer's disease and smoking indicates that smoking cigarettes is a significant risk factor for the disease. After controlling for study design, quality of the journals, time of publication, and tobacco industry affiliation of the authors, the UCSF research team also found an association between tobacco industry affiliation and the conclusions of individual studies.

4 Feb 2010

Sistemic to develop SistemRNA compound-centric drug discovery technology with closed series A funds

Fast growing Scottish biotech company Sistemic Ltd today announced that it had closed a series A funding round with lead investors ChimeraBio and the Scottish Enterprise Scottish Co-Investment Fund. The company will use the funding to further develop its proprietary SistemRNA compound-centric drug discovery technology. Using SistemRNA shortens the odds in drug discovery by enabling far more accurate prediction of potential drug indications, interactions and side effects.

4 Feb 2010

Verizon Business to provide secure private IP network for Eurofins Scientific

Under a three-year extension of an existing relationship, Verizon Business will securely connect 16 key Eurofins laboratories and research centers in Europe, Asia and the U.S. with the company's global customer base.

4 Feb 2010

Type 1 diabetes: Regeneration exhibits potential as a possible cure

A hormone responsible for the body's stress response is also linked to the growth of insulin-producing cells in the pancreas, according to JDRF- funded researchers at the Salk Institute for Biological Studies in California. The findings are the latest advances to underscore the potential for regeneration as a key component of a possible cure for type 1 diabetes.

4 Feb 2010

FRG announces new molecular imaging division

Foundation Radiology Group (FRG), a premier provider of diagnostic imaging professional services, headquartered in downtown Pittsburgh, is pleased to announce its new division, FRG Molecular Imaging, which will be led by nationally renowned physician and PET/CT imaging pioneer, Todd M. Blodgett, M.D..

4 Feb 2010

Unisys' Mexican subsidiary wins contract to develop biometric citizen identification solution

Unisys today announced that its Mexican subsidiary has been awarded a contract by the Secretaria de Gobernacion/Registro Nacional de Poblacion (Mexican Ministry of Internal Affairs/National Citizen Registry) to create and manage an advanced citizen identification solution using biometric technologies.

4 Feb 2010

Finland commits 1.85M as initial funding for development of European biomedical research infrastructures

Finland has made its first specific commitment to the development of European biomedical research infrastructures (BMS ESFRIs) by supporting a joint pilot infrastructure project in bioinformatics (ELIXIR), biobanking (BBMRI) and translational research (EATRIS). The initial commitment of 1.85 M- is to support preparation and pilot studies in 2010.

4 Feb 2010

Waiting for birth as effective as inducing labor for intrauterine growth restriction

In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, in Chicago, researchers will unveil findings that show that waiting for birth is as effective as inducing labor in cases of intrauterine growth restriction (IUGR).

4 Feb 2010

Health Discovery receives final patent infringement payment from Vermillion

Health Discovery Corporation announced today that the Company has received the final payment that was due under the agreement that settled the Company’s patent infringement lawsuit against Vermillion, formerly known as Ciphergen Biosystems, Inc.

4 Feb 2010

Researchers develop simple urine test to predict and diagnose preeclampsia

Researchers at Yale School of Medicine have developed a simple urine test to rapidly predict and diagnose preeclampsia, a common, but serious hypertensive complication of pregnancy.

4 Feb 2010

EUCODIS Bioscience to utilize EUR 2M capital injection for adding enzyme families and development of international markets

EUCODIS Bioscience, a company providing customized enzymes to the pharmaceutical, chemical, and other industries, announced today that it has received a cash injection of EUR 2 million from existing shareholders.

4 Feb 2010